A paper presented at the American Society of Hematology describes early cost and utilization results for Medicare patients.
Read More
A paper presented at the American Society of Hematology describes early cost and utilization results for Medicare patients.
The Alliance for Regenerative Medicine releases a sponsored study of the cost-effectiveness analysis of new cell and gene therapies.
New “precision” medicines are being approved with fewer and small trials, which may raise safety questions.